View Post

Risk varies for breast cancer spreading to other body parts

In In The News by Barbara Jacoby

By: Amerigo Allegretto From: auntminnie.com The risk that a woman with early breast cancer will see it spread to another part of the body can be up to 22%, according to a global study presented at the Advanced Breast Cancer Sixth International Consensus Conference, being held November 4-6 in Lisbon. In her presentation, Eileen Morgan, PhD, from the World Health …

View Post

Elderly patients with SLE, breast cancer at increased risk for mortality

In In The News by Barbara Jacoby

By Jason Laday From: healio.com Systemic lupus erythematosus is a risk factor for increased mortality in elderly patients with early breast cancer, according to data published in Arthritis Care & Research. “Prior research has shown that elderly patients with rheumatoid arthritis with concomitant breast or prostate cancer have increased mortality when compared to patients without rheumatoid arthritis,” Sebastian Bruera, MD, …

View Post

Study Shows CARG-BC Score is Excellent Predictive Tool

In Clinical Studies News by Barbara Jacoby

By: Eleonora Teplinsky, MD From: medpagetoday.com For severe and life-threatening toxicity from chemotherapy in older adults with early breast cancer The number of breast cancer cases in the U.S. is growing annually, and a greater than 50% increase in diagnoses is expected from 2011 to 2030. The number of cases diagnosed in women ages 70 to 84 is expected to …

View Post

Cryoablation Technology for Early Breast Cancer Earns Breakthrough Therapy Designation

In In The News by Barbara Jacoby

By: Audrey Sternberg From: cancernetwork.com The next-generation cryoablation technology ProSense was granted breakthrough device designation to treat certain patients with T1 breast tumors. Breakthrough device designation was granted to the next-generation cryoablation technology ProSense for use in patients with T1 invasive breast cancer as well as in patients not suitable for surgical alternatives for the treatment of their tumors, reported IceCure …

View Post

Positive decision from SMC on Takeda’s breast cancer treatment

In In The News by Barbara Jacoby

By Emma Cooper From: pharmafield.co.uk The Scottish Medicines Consortium (SMC) has accepted Takeda’s PROSTAP® SR DCS & PROSTAP® 3 DCS (leuprorelin acetate) for use in patients with early breast cancer and advanced breast cancer.1,2,*,† Leuprorelin acetate belongs to a family of drugs called gonadotrophin-releasing hormone (GnRH) agonists which is used as adjuvant treatment in combination with tamoxifen or an aromatase …

View Post

Statins during chemo may limit heart damage in breast cancer patients

In In The News by Barbara Jacoby

By: Erica Carbajal From: beckershospitalreview.com Women with early breast cancer who received statins, or cholesterol-lowering drugs, during their chemotherapy had a lower risk of heart failure in the five years after their cancer treatment, according to a study published in the Journal of the American Heart Association Jan. 6. Researchers analyzed data from newly diagnosed breast cancer patients age 66 …

View Post

MI May Fuel Breast Cancer Recurrence, Mortality

In Clinical Studies News by Barbara Jacoby

By: Charles Bankhead, Senior Editor From: medpagetoday.com In survivors of early breast cancer, cardiovascular events significantly increased the risk of cancer recurrence and cancer death, a review of 1,700 patients showed. The risk of breast cancer recurrence increased by 59% and cancer-specific death by 60% in patients who had a heart attack, stroke, or heart failure after cancer diagnosis and …

View Post

Samsung Bioepis’ biosimilar breast cancer treatment scores FDA’s nod

In Clinical Studies News by Barbara Jacoby

From: koreabiomed.com Samsung Bioepis said Friday that the U.S. Food and Drug Administration has granted sales approval for Ontruzant 420mg, a trastuzumab biosimilar (Original: Herceptin). Ontruzant treats patients with early breast cancer, metastatic breast cancer, and metastatic gastric cancer. Its original, Herceptin, is one of the world’s most purchased medicines, with an annual sale of 7.2 trillion won ($5.7 billion) …

Are some breast cancer patients getting too much radiation?

In In The News by Barbara Jacoby

By: Kathleen Doheny From: cbsnews.com More than half of older American women with early breast cancer may get more radiation therapy than needed, which significantly boosts medical costs, a new study indicates. Analyzing 2011 data on breast cancer patients, researchers estimated $164 million could have been saved by ordering a shorter radiation course. “Women who were eligible for shorter radiation …

View Post

Shorter course of radiation better for early stage breast cancer

In In The News by Barbara Jacoby

By: Stephen Feller From: upi.com Women treated for early breast cancer with shorter courses of radiation than standardly prescribed had a higher quality of life than those with longer treatment plans and no difference in controlling the growth of tumors, according to two new studies. Generally speaking, women have received conventionally fractionated whole breast irradiation, or CF-WBI, which uses smaller …